Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial-Reference-Cited by-同舟云学术

Preference of elderly patients’ to oral or intravenous chemotherapy in heavily pre-treated recurrent ovarian cancer: final results of a prospective multicenter trial

Published:2017-03-07 Issue:1 Volume:4 Page:
ISSN:2053-6844
Container-title:Gynecologic Oncology Research and Practice
language:en
Short-container-title:gynaecol oncol res pract

Author:

Chekerov Radoslav^ORCID, ,Harter Philipp,Fuxius Stefan,Hanker Lars Christian,Woelber Linn,Müller Lothar,Klare Peter,Abenhardt Wolfgang,Nedkova Yoana,Yalcinkaya Isil,Heinrich Georg,Sommer Harald,Mahner Sven,Wimberger Pauline,Koensgen-Mustea Dominique,Richter Rolf,Oskay-Oezcelik Gülten,Sehouli Jalid

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40661-017-0040-2.pdf

Reference40 articles.

1. Bonanni B, Lazzeroni M. Acceptability of chemoprevention trials in high-risk subjects. Ann Oncol. 2013;24 Suppl 8:viii42–6.

2. Hall M, Rustin G. Recurrent ovarian cancer: when and how to treat. Curr Oncol Rep. 2011;13:459–71.

3. Hilpert F, Wimberger P, du Bois A, Pfisterer J, Harter P. Treatment of elderly ovarian cancer patients in the context of controlled clinical trials: a joint analysis of the AGO Germany experience. Onkologie. 2012;35:76–81.

4. Colombo N, et al. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v23–30.

5. Lambrou NC, Bristow RE. Ovarian cancer in elderly women. Oncology (Huntingt). 2003;17:1075–81. discussion 1081, 1085-1076, 1091.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sexuality as a Prognostic Factor—Results of an Individual Patient Data NOGGO (North-Eastern German Society of Gynecological Oncology)-Meta-Analysis of 644 Recurrent Ovarian Cancer Patients Prior to Chemotherapy;Cancers;2024-02-16

2. Key aspects of medication adherence to oral anticancer drugs: A literature review;Meditsinskiy sovet = Medical Council;2024-01-17

3. Interpatient Heterogeneity in Drug Response and Protein Biomarker Expression of Recurrent Ovarian Cancer;Cancers;2022-05-03

4. Translation and psychometric evaluation of the German version of the IcanSDM measure – a cross-sectional study among healthcare professionals;BMC Health Services Research;2021-06-02

5. Treosulfan in platinum-resistant ovarian cancer;International Journal of Gynecologic Cancer;2021-05-18